Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

therapeutics   crawled date : 2021 - 10 - 07    save search

Y-mAbs’ 177Lu-omburtamab-DTPA for the Treatment of Patients with Medulloblastoma Granted Rare Pediatric Disease Designation by FDA
Published: 2021-10-07 (Crawled : 23:00) - biospace.com/
YMAB | $15.26 -0.52% -0.52% 160K twitter stocktwits trandingview |
Health Technology
| | O: 0.97% H: 3.54% C: -1.49%

disease treatment fda rare pediatric disease designation granted designation rare
Loxo Oncology at Lilly Announces Details of Presentations at 2021 AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
Published: 2021-10-07 (Crawled : 23:00) - biospace.com/
LLY | News | $732.2 -1.81% 0.18% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.56% H: 2.18% C: 1.77%

presentation molecular cancer conference
Prelude Therapeutics Announces Presentation of Encouraging Data from Multiple Programs at the AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
Published: 2021-10-07 (Crawled : 23:00) - biospace.com/
PRLD | $3.91 1.03% 1.02% 29K twitter stocktwits trandingview |
Health Technology
| | O: -14.52% H: 0.0% C: -29.51%

presentation molecular cancer conference
Repare Therapeutics Issues Statement Regarding Inadvertent Issuance of Phase 1/2 TRESR RP-3500 Clinical Trial Abstract by the AACR-NCI-EORTC Virtual International Conference
Published: 2021-10-07 (Crawled : 23:00) - biospace.com/
RPTX 4 | $3.3 -1.79% -1.82% 73K twitter stocktwits trandingview |
Health Technology
| | O: -0.32% H: 0.28% C: -11.87%

phase 1 trial conference
Aditxt to Present at the LD Micro Main Event in Los Angeles on October 13, 2021
Published: 2021-10-07 (Crawled : 22:00) - biospace.com/
ADTX | $2.27 2.84% 27K twitter stocktwits trandingview |
Health Technology
| | O: -1.91% H: 8.31% C: 4.55%


Immunotherapeutic Benefits of the DPX Delivery Platform Featured in Two Poster Presentations at the AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics
Published: 2021-10-07 (Crawled : 22:00) - biospace.com/
IMV | $0.8225 -2.74% 45K twitter stocktwits trandingview |
Health Technology
| | O: 0.93% H: 1.84% C: -1.84%

presentation molecular cancer liver conference
LAVA Therapeutics to Present its Bispecific Gamma Delta T Cell Engagers for Treatment of Cancer at the 2021 AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
Published: 2021-10-07 (Crawled : 21:00) - biospace.com/
LVTX | $2.77 -7.05% -7.58% 150K twitter stocktwits trandingview |
| | O: -3.3% H: 5.92% C: 0.77%

treatment molecular cancer conference t-cell
Cidara Therapeutics Announces Commencement of Concurrent Public Offerings of Common Stock and Preferred Stock
Published: 2021-10-07 (Crawled : 21:00) - biospace.com/
CDTX | News | $11.94 16.49% 14.15% 170K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.0% C: -1.58%

offering
Allogene Therapeutics Reports FDA Clinical Hold of AlloCAR T Trials Based on a Single Patient Case in ALPHA2 Trial
Published: 2021-10-07 (Crawled : 21:00) - biospace.com/
ALLO | $3.04 -9.79% -10.86% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.42% H: 3.86% C: 1.29%

fda trials trial clinical hold
Bicycle Therapeutics Announces Interim BT5528 Phase I Clinical Trial Results and Preliminary Results from Ongoing BT8009 Phase I Clinical Trial
Published: 2021-10-07 (Crawled : 21:00) - biospace.com/
BCYC | $22.7 0.09% 0.09% 520K twitter stocktwits trandingview |
Health Technology
| | O: -1.13% H: 21.05% C: 18.09%

ongoing results trial trial results
Mirati Therapeutics to Collaborate with Sanofi on Phase 1/2 Study Evaluating Combination of adagrasib with a SHP2 Inhibitor in KRAS G12C-mutated Lung Cancer
Published: 2021-10-07 (Crawled : 21:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480 twitter stocktwits trandingview |
Health Technology
| | O: -4.14% H: 5.79% C: 5.79%
SNY | News | $46.66 -2.16% -2.21% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: 0.21% H: 0.95% C: 0.62%
MRTX | $58.7 -0.17% 0.34% 0 twitter stocktwits trandingview |
Health Technology
| | O: -1.07% H: 8.36% C: 4.51%

lung cancer phase 1 cancer
CORRECTING and REPLACING: LAVA Therapeutics to Present its Bispecific Gamma Delta T Cell Engagers for Treatment of Cancer at the 2021 AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
Published: 2021-10-07 (Crawled : 18:00) - globenewswire.com
LVTX | $2.77 -7.05% -7.58% 150K twitter stocktwits trandingview |
| | O: -3.3% H: 5.92% C: 0.77%

treatment molecular cancer conference t-cell
Intergalactic Therapeutics Launches with $75 Million Series A
Published: 2021-10-07 (Crawled : 17:00) - biospace.com/
CTS | News | $45.64 0.33% 0.0% 94K twitter stocktwits trandingview |
Electronic Technology
| | O: 0.99% H: 1.71% C: 0.7%

therapeutics
GBT Announces New Employment Inducement Grants
Published: 2021-10-07 (Crawled : 15:00) - globenewswire.com
GBT | $68.49 0.02% -0.02% twitter stocktwits trandingview |
Health Technology
| | O: 5.12% H: 6.14% C: 4.12%

granted grant
Rain Therapeutics Presents Data on Milademetan (RAIN-32) at the 2021 AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
Published: 2021-10-07 (Crawled : 14:15) - globenewswire.com
RAIN | $1.21 0.0% 3.7M twitter stocktwits trandingview |
Manufacturing
| | O: -0.54% H: 2.3% C: -7.71%

molecular cancer conference
Phio Pharmaceuticals Presents New BRD4 Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Published: 2021-10-07 (Crawled : 13:15) - investors.phiopharma.com
PHIO | News | $0.672 -4.0% -4.17% 91K twitter stocktwits trandingview |
Health Technology
| | O: 2.81% H: 0.55% C: -0.55%

molecular cancer conference
Talem Therapeutics Announces Multi-Target Antibody Discovery Research Collaboration With Pierre Fabre
Published: 2021-10-07 (Crawled : 13:15) - biospace.com/
IPA | $1.22 -0.81% 23K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: 0.67% H: 13.59% C: 3.18%

collaboration antibody research
Monte Rosa Therapeutics Presents Preclinical Data at AACR-NCI-EORTC Highlighting Potential of Molecular Glue Degraders for the Treatment of Myc-driven Cancer
Published: 2021-10-07 (Crawled : 13:15) - globenewswire.com
GLUE | $5.46 -1.44% -1.47% 83K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: 0.1% H: 3.64% C: -2.44%

treatment rosa potential molecular cancer preclinical pre-clinical
Ovid Therapeutics Appoints Dr. Kevin Fitzgerald to Board of Directors
Published: 2021-10-07 (Crawled : 13:15) - biospace.com/
OVID | $3.165 -1.09% -1.11% 110K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 5.23% C: 4.36%

therapeutics
Merus Presents Early Clinical Data on MCLA-158 and Preclinical Data on Zenocutuzumab at the AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
Published: 2021-10-07 (Crawled : 13:15) - globenewswire.com
MRUS | $41.96 2.79% 2.72% 740K twitter stocktwits trandingview |
Health Technology
| | O: 45.75% H: 2.13% C: -5.69%

molecular cancer conference preclinical pre-clinical
Gainers vs Losers
62% 38%

Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M twitter stocktwits trandingview |
Consumer Services

BOF | $1.99 70.09% 41.21% 110M twitter stocktwits trandingview |

ILAG | $0.51 6.03% 40.62% 1.7M twitter stocktwits trandingview |

LICN | $0.941 68.04% 40.49% 15M twitter stocktwits trandingview |

AMST | $3.31 65.5% 39.58% 70M twitter stocktwits trandingview |
Technology Services

MTC | $3.615 61.38% 38.04% 9.3M twitter stocktwits trandingview |
Technology Services

WIMI | $1.15 58.53% 36.92% 19M twitter stocktwits trandingview |
Technology Services

AIH | $0.45 12.5% 30.92% 320K twitter stocktwits trandingview |
Health Services

MULN | News | $3.78 38.46% 27.78% 13M twitter stocktwits trandingview |
Information

RILY | $29.86 37.48% 27.26% 12M twitter stocktwits trandingview |
Finance


Your saved searches
Save your searches and get alerts when important news are released.